Literature DB >> 11023167

Asymmetrical septal hypertrophy in newborn infants of diabetic mothers.

M M Vela-Huerta1, A Vargas-Origel, A Olvera-López.   

Abstract

The objective of this paper is to determine the frequency and outcome of asymmetrical septal hypertrophy (ASH) in large-for-gestational-age infants (LGA) born to diabetic (DM) and nondiabetic mothers (NDM), and to establish the relationship between ASH and maternal diabetes control. A comparative study was design to assess ASH in infants born to DM and NDM. The study was conducted in the Departments of Neonatology and Pediatric Cardiology of the "Hospital de Gineco-Pediatria 48", Instituto Mexicano del Seguro Social from January to December 1997. Eighty-five full-term infants of DM (group A) and 85 LGA infants of NDM (group B) were included. As a control group (group C), we studied 85 healthy, full-term infants. In all cases a Doppler echocardiogram was obtained in the first 48 h after birth, and for the ASH infants, at 2 and 4 months. Chest X ray, electrocardiogram, and laboratory tests were performed as complementary studies. ASH was present in 38.8% of LGA infants of DM and in 7.1% of NDM. The difference was significant (p < 0.01). Interventricular septum (IVS) and IVS/ posterior wall of left ventricle ratio were significantly different between groups A and B with C. There was no correlation between Hb A1 level and the presence of ASH in group A. ASH is a common finding in infants of DM. We could not find a relationship between the degree of metabolic control during pregnancy and the incidence and severity of ASH.

Entities:  

Mesh:

Year:  2000        PMID: 11023167     DOI: 10.1055/s-2000-9267

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  7 in total

1.  Intrapartum Fetal Electrocardiogram in Small- and Large-for-Gestational Age Fetuses.

Authors:  Lena Braginsky; Steven J Weiner; George R Saade; Michael W Varner; Sean C Blackwell; Uma M Reddy; John M Thorp; Alan T N Tita; Russell S Miller; David S McKenna; Edward K S Chien; Dwight J Rouse; Yasser Y El-Sayed; Yoram Sorokin; Steve N Caritis
Journal:  Am J Perinatol       Date:  2021-08-31       Impact factor: 1.862

2.  Fetal echocardiographic parameters in pregnancies complicated by diabetes: a case control study.

Authors:  Amal Darwish; Maged Abdel-Raouf; Rasha Kamel; Emad Salah; Mai Salah; Ahmed Okasha
Journal:  BMC Pregnancy Childbirth       Date:  2022-08-18       Impact factor: 3.105

3.  Troponin T and NT ProBNP Levels in Gestational, Type 1 and Type 2 Diabetic Mothers and Macrosomic Infants.

Authors:  Mustafa Kurthan Mert; Mehmet Satar; Nazan Özbarlas; Akgün Yaman; Fatma Tuncay Özgünen; Hüseyin Selim Asker; Eren Kale Çekinmez; Tamer Tetiker
Journal:  Pediatr Cardiol       Date:  2015-08-13       Impact factor: 1.655

4.  Cardiac function in 7-8-year-old offspring of women with type 1 diabetes.

Authors:  Maarten Rijpert; Johannes M P J Breur; Inge M Evers; Harold W de Valk; Cobi J Heijnen; Folkert J Meijboom; Gerard H A Visser
Journal:  Exp Diabetes Res       Date:  2011-11-15

5.  Maternal Hyperglycemia Directly and Rapidly Induces Cardiac Septal Overgrowth in Fetal Rats.

Authors:  Erin E Gordon; Benjamin E Reinking; Shanming Hu; Jianrong Yao; Kok L Kua; Areej K Younes; Chunlin Wang; Jeffrey L Segar; Andrew W Norris
Journal:  J Diabetes Res       Date:  2015-05-07       Impact factor: 4.011

6.  Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways.

Authors:  Benjamin E Reinking; Elesa W Wedemeyer; Robert M Weiss; Jeffrey L Segar; Thomas D Scholz
Journal:  Cardiovasc Diabetol       Date:  2009-07-31       Impact factor: 9.951

7.  Prediction of Fetal Hypertrophic Cardiomyopathy in Diabetic Pregnancies Compared with Postnatal Outcome.

Authors:  Sherif F Elmekkawi; Ghada M Mansour; Mohammed S E Elsafty; Alaa S Hassanin; Mohamed Laban; Heba M Elsayed
Journal:  Clin Med Insights Womens Health       Date:  2015-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.